Is DHR or GSK cheaper?

On trailing earnings, GSK is cheaper: DHR trades at a 34.01 P/E and GSK at 11.36.

Which has grown faster, DHR or GSK?

Over the past five years, DHR grew revenue faster — DHR at a 1.97% CAGR versus GSK at 0.63%.

Does DHR or GSK pay a bigger dividend?

DHR yields 0.54% and GSK yields 3.50% based on trailing dividends and the latest price.

Is DHR or GSK more profitable?

GSK runs the higher net margin — DHR at 15.95% versus GSK at 17.76%.

Which has been the better investment, DHR or GSK?

Over the past 10-year, DHR delivered the higher annualized total return — DHR at 10.83% versus GSK at 6.48%. Past performance doesn't predict future results.

Danaher Corporation (DHR) vs GSK plc (GSK)

GSK leads on 15 of 17 compared metrics.

A side-by-side comparison of Danaher Corporation and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 25, 2026. The ● marks the stronger figure on each row (cheaper multiple, higher margin/return).

DHR

Danaher Corporation

$134.62B

$191.50HealthcareAt close: Jul 24, 2026, 4:00 PM ET

GSK

GSK plc

$103.60B

$51.35HealthcareDelayed quote: Jul 24, 2026, 4:00 PM EDT

Total return — DHR vs GSK

growth of $100 · dividends reinvested · last 30y

DHR +6398.0%GSK +576.1%DHR compounded faster

Log scale — wide-divergence pair

DHR GSK

DHR vs GSK: by the numbers

•DHR is the larger company ($134.62B vs $103.60B market cap).
•GSK trades at the lower earnings multiple (11.36 vs 34.01 P/E).
•GSK converts more revenue to profit (17.76% vs 15.95% net margin).
•DHR grew revenue faster over the past five years (1.97% vs 0.63% CAGR).
•GSK pays the higher dividend yield (3.50% vs 0.54%).

Which is better, DHR or GSK?

Metric tally: DHR 2 · GSK 15

It depends on what you're optimizing for:

ValueGSK(lower P/E)

GrowthDHR(faster 5Y revenue CAGR)

IncomeGSK(higher dividend yield)

QualityGSK(higher ROIC)

Metrics side by side

Valuation

Metric	DHR	GSK
P/E ratio	34.01	11.36●
Forward P/E	22.57	14.35●
P/S ratio	5.40	2.37●
P/B ratio	2.58●	3.36
PEG ratio	85.04	0.02●
EV / EBITDA	24.02	8.47●
FCF yield	4.03%	8.05%●

Profitability

Metric	DHR	GSK
Gross margin	58.51%	72.67%●
Operating margin	20.42%	25.65%●
Net margin	15.95%	17.76%●
ROE	7.61%	25.19%●
ROIC	5.72%	16.61%●

Dividends

Metric	DHR	GSK
Dividend yield	0.54%	3.50%●
Payout ratio	20.51%	23.66%

Growth (annualized)

Metric	DHR	GSK
Revenue CAGR (5Y)	1.97%●	0.63%
EPS CAGR (5Y)	0.40%	14.05%●
FCF CAGR (5Y)	-2.83%	-0.35%●
Total return CAGR (5Y)	-5.34%	9.84%●

Frequently asked

Which is better, DHR or GSK?: It depends on your goal. value: GSK (lower P/E); growth: DHR (faster 5Y revenue CAGR); income: GSK (higher dividend yield); quality: GSK (higher ROIC). Across all compared metrics, GSK leads 15 to 2.
Is DHR or GSK cheaper?: On trailing earnings, GSK is cheaper: DHR trades at a 34.01 P/E and GSK at 11.36.
Which has grown faster, DHR or GSK?: Over the past five years, DHR grew revenue faster — DHR at a 1.97% CAGR versus GSK at 0.63%.
Does DHR or GSK pay a bigger dividend?: DHR yields 0.54% and GSK yields 3.50% based on trailing dividends and the latest price.
Is DHR or GSK more profitable?: GSK runs the higher net margin — DHR at 15.95% versus GSK at 17.76%.
Which has been the better investment, DHR or GSK?: Over the past 10-year, DHR delivered the higher annualized total return — DHR at 10.83% versus GSK at 6.48%. Past performance doesn't predict future results.

Go deeper

Full DHR analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Danaher P/E ratio GSK P/E ratio Danaher dividend yield GSK dividend yield Danaher ROE GSK ROE Danaher operating margin GSK operating margin Danaher revenue growth GSK revenue growth Danaher free cash flow GSK free cash flow

Danaher & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Lowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 25, 2026.